BRAFV600E and Microenvironment in Thyroid Cancer: A Functional Link to Drive Cancer Progression

Abstract excerpt

Papillary thyroid cancer (PTC) rates continue to increase in the United States and Europe, and, although most patients do well, some recur and die of their disease. Patients with PTC harboring the BRAF(V600E) mutation seem to display a more aggressive clinical behavior, but little is known about the role of this mutation in crucial processes in the tumor microenvironment, such as tumor adhesion, migration,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell Adhesion Molecules Research
• Share to S100 Proteins and Annexins
• Share to Thyroid Cancer Diagnosis and Treatment